Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by ANGLE plc

< Previous 1 2 Next >
Angle PLC Announces Issue of Equity
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Result of 2022 Annual General Meeting
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Issue of Equity
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Secured Contract From Pharma Services Customer
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Predicting Immunotherapy Response in SCLC
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Potential Role of Invasive Cellular Protrusions
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Partnership with Major United States Urology Group
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Molecular Characterisation of CTCs
From ANGLE plc
Via AccessWire
Tickers ANPCY
ANGLE receives FDA clearance for Parsortix
From ANGLE plc
Via AccessWire
Exposures Product Safety
Tickers ANPCY
Angle PLC - Prostate Cancer UK Funds New Study Using Parsortix
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Preliminary Results
From ANGLE plc
Via AccessWire
Exposures Product Safety
Tickers ANPCY
Angle PLC Announces Notice of Preliminary Results and Webcast
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Poster on Parsortix System Presented at AACR 2022
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Identifying Drug Targets in Cancer Metastasis
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Rapid Information on Patient Response to Therapies
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Identifying Therapeutic Targets in TNBC Patients
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Update on Laboratory Accreditation
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Holding(s) in Company
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Issue of Equity
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Potential in Immunotherapy Treatment Selection
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Concordance of Parsortix with tissue biopsy
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Update on Lab Accreditation and Ovarian Study
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Insight into Drug Resistance in NSCLC
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Issue of Equity
From ANGLE plc
Via AccessWire
Tickers ANPCY
Angle PLC Announces Issue of Equity
From ANGLE plc
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers ANPCY
Angle PLC Announces Parsortix in RNA analysis of CTCs as tool in NSCLC
From ANGLE plc
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property Product Safety
Tickers ANPCY
Angle PLC Announces Issue of Equity
From ANGLE plc
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers ANPCY
Angle PLC Announces Issue of Equity
From ANGLE plc
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers ANPCY
Angle PLC Announces Issue of LTIP Options and Share Options
From ANGLE plc
Via AccessWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property Product Safety
Tickers ANPCY
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.